Chad Conner

Chief Operating Officer presso HOMETOWN INTERNATIONAL, INC.

49 anni

Health Technology

Retail Trade

Profilo

Chad S.
Conner is currently the Chief Executive Officer & Director at Mycrodose Therapeutics, Inc. since 2020 and the Chief Operating Officer at Makamer Holdings, Inc. since 2022.
Previously, he served as the Chief Executive Officer & Director at Pure Ratios Holdings, Inc. from 2015 to 2021.

Posizioni attive di Chad Conner

Società	Posizione	Inizio
HOMETOWN INTERNATIONAL, INC.	Chief Operating Officer	01/04/2022
Mycrodose Therapeutics, Inc. Mycrodose Therapeutics, Inc. BiotechnologyHealth Technology Mycrodose Therapeutics, Inc. is a US-based pharmaceutical company that specializes in developing advanced drug delivery systems using DEA Schedule I & III drugs and other compounds to treat cancer-related conditions, mental health, and cognitive degenerative diseases. Mycrodose Therapeutics is one of the few private companies that have been granted a Schedule I license and approved by the United States Drug Enforcement Agency (DEA), State of Attorney Generals Research Advisory Board, and the US Food & Drug Administration (FDA) to research four psychedelic compounds: psilocybin, LSD, MDMA, and DMT. The company is based in San Diego, CA, and was founded in 2020. The company's IP-protected sustained microdosing technology™ is a safer and smarter approach to delivering pharmaceutical compounds to patients of all ages, allowing for an expandable and scalable business model. Chad S. Conner has been the CEO of the company since 2020.	Chief Executive Officer	01/11/2020

Tutte le posizioni attive di Chad Conner

Precedenti posizioni note di Chad Conner

Società	Posizione	Fine
Pure Ratios Holdings, Inc. Pure Ratios Holdings, Inc. Pharmaceuticals: OtherHealth Technology Pure Ratios Holdings, Inc. develops and manufactures traditional Chinese medicines with cannabis including the integration of hemp derived CBD. The company was founded by William A. Conner in 2015 and is headquartered in San Diego, CA.	Chief Executive Officer	01/03/2021

Vedi nel dettaglio l'esperienza di Chad Conner

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Chad Conner

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
HOMETOWN INTERNATIONAL, INC.	Retail Trade

Aziende private	2
Pure Ratios Holdings, Inc. Pure Ratios Holdings, Inc. Pharmaceuticals: OtherHealth Technology Pure Ratios Holdings, Inc. develops and manufactures traditional Chinese medicines with cannabis including the integration of hemp derived CBD. The company was founded by William A. Conner in 2015 and is headquartered in San Diego, CA.	Health Technology
Mycrodose Therapeutics, Inc. Mycrodose Therapeutics, Inc. BiotechnologyHealth Technology Mycrodose Therapeutics, Inc. is a US-based pharmaceutical company that specializes in developing advanced drug delivery systems using DEA Schedule I & III drugs and other compounds to treat cancer-related conditions, mental health, and cognitive degenerative diseases. Mycrodose Therapeutics is one of the few private companies that have been granted a Schedule I license and approved by the United States Drug Enforcement Agency (DEA), State of Attorney Generals Research Advisory Board, and the US Food & Drug Administration (FDA) to research four psychedelic compounds: psilocybin, LSD, MDMA, and DMT. The company is based in San Diego, CA, and was founded in 2020. The company's IP-protected sustained microdosing technology™ is a safer and smarter approach to delivering pharmaceutical compounds to patients of all ages, allowing for an expandable and scalable business model. Chad S. Conner has been the CEO of the company since 2020.	Health Technology